National Coalition for LGBTQ Health

All resources of the type

News

GovTrack.us

May 29, 2025

GovTrack.us tracks the activities of the United States Congress and the White House to make a more open and accountable government. Check the status of federal legislation, and find information about the voting record of your elected representative and senators.

Fears new mpox strain spreading in UK after case with no travel history

April 7, 2025

The Telegraph: The UK Health Security Agency has launched an investigation to determine how a person in North East England caught the virus.

Fact Sheet: Update on the Biden-⁠Harris Administration’s Commitment to Addressing the Global Mpox Outbreak

December 19, 2024

Archived update from the White House from December 2024. During the 2022 global outbreak of clade II mpox, the Biden-Harris Administration mounted a robust response by making vaccines, tests, and treatment available to those at risk in the United States and abroad.

CDC Advisory: First Case of Clade I Mpox Diagnosed in the United States

November 18, 2024

On November 15, 2024, the California Department of Public Health (CDPH) confirmed the first reported case of clade I mpox in the United States. This individual had recently traveled to areas experiencing clade I monkeypox virus (MPXV) transmission and sought medical care for mpox symptoms in the United States.

Global strategic preparedness and response plan launched by WHO to contain mpox outbreak

August 26, 2024

The World Health Organization (WHO) today launched a global Strategic Preparedness and Response Plan to stop outbreaks of human-to-human transmission of mpox through coordinated global, regional, and national efforts. This follows the declaration of a public health emergency of international concern by the WHO Director-General on 14 August 2025.

Guidance for Tecovirimat (TPOXX)

July 9, 2024

Tecovirimat (TPOXX) and Guidance for Tecovirimat Use pages are now live.

Bavarian Nordic Announces Commercial Launch of Mpox Vaccine in the U.S.

April 2, 2024

JYNNEOS®, the only FDA-approved mpox vaccine, is now commercially available in the U.S.

National Coalition for LGBTQ Health

1630 Connecticut Ave. NW, Suite 500
Washington, DC 20009

202-232-6749 | [email protected]


© Copyright 2025 National Coalition for LGBTQ Health. All rights reserved. | Privacy Policy | Site Map